Docoh
Loading...

ABT Abbott Laboratories

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Its portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

Company profile

Ticker
ABT
Exchange
Website
CEO
Robert Ford
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
360698440

ABT stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

19 Feb 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
1 Apr 21 Randel William Woodgrift Common shares without par value Payment of exercise Dispose F No No 119.84 1,368 163.94K 49,093
1 Apr 21 Christopher J Scoggins Common shares without par value Payment of exercise Dispose F No No 119.84 1,223 146.56K 46,121
31 Mar 21 Alpern Robert J Stock Equivalent Units Common Shares Grant Aquire A No No 119.84 65 7.79K 8,308
31 Mar 21 John G Stratton Stock Equivalent Units Common Shares Grant Aquire A No No 119.84 275 32.96K 6,345
3 Mar 21 Andrea F Wainer Common shares without par value Sell Dispose S No No 121.79 6,200 755.1K 51,550

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

73.7% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 2399 2256 +6.3%
Opened positions 245 167 +46.7%
Closed positions 102 102
Increased positions 917 845 +8.5%
Reduced positions 894 910 -1.8%
13F shares
Current Prev Q Change
Total value 142.8B 140.91B +1.3%
Total shares 1.3B 1.29B +1.3%
Total puts 6.58M 7.08M -7.1%
Total calls 7.46M 7.11M +5.0%
Total put/call ratio 0.9 1.0 -11.5%
Largest owners
Shares Value Change
Vanguard 147.27M $16.12B -0.6%
BLK Blackrock 133.43M $14.61B -1.2%
Capital Research Global Investors 86.39M $9.46B -1.2%
STT State Street 71.33M $7.81B -3.2%
Capital International Investors 53.59M $5.87B -4.3%
Wellington Management 31.18M $3.41B -10.9%
Massachusetts Financial Services 27.1M $2.97B +5.3%
MS Morgan Stanley 26.69M $2.92B +5.2%
NTRS Northern Trust 26.42M $2.89B -2.2%
Geode Capital Management 25.64M $2.8B +1.4%
Largest transactions
Shares Bought/sold Change
Norges Bank 17.18M +17.18M NEW
Wellington Management 31.18M -3.82M -10.9%
FMR 18.14M +3.06M +20.3%
BAC Bank Of America 23.88M -2.44M -9.3%
Capital International Investors 53.59M -2.39M -4.3%
Citadel Advisors 159.72K -2.36M -93.7%
STT State Street 71.33M -2.34M -3.2%
Harding Loevner 390 -2.2M -100.0%
Winslow Capital Management 0 -2.18M EXIT
BNP Paribas Arbitrage 281.02K -1.65M -85.5%

Financial report summary

?
Management Discussion
  • The increase in Total Net Sales in 2020 reflects volume growth in the Diagnostics and Nutritional Products segments.  In Medical Devices, the impact of COVID-19 on Abbott’s cardiovascular and neuromodulation businesses was partially offset by double-digit volume growth in Diabetes Care.  The increase in Total Net Sales in 2019 reflects volume growth across all of Abbott’s segments.  The price declines related to the Medical Devices segment in 2020 and 2019 primarily reflect DES pricing pressures as a result of market competition in the U.S. and other major markets.
  • A comparison of significant product and product group sales is as follows.  Percent changes are versus the prior year and are based on unrounded numbers.
  • In order to compute results excluding the impact of exchange rates, current year U.S. dollar sales are multiplied or divided, as appropriate, by the current year average foreign exchange rates and then those amounts are multiplied or divided, as appropriate, by the prior year average foreign exchange rates.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: abnormal, AdviseDx, aggressive, Ahlberg, Amulet, antibody, antigen, app, Asian, athletic, attestation, began, BinaxNOW, Biosensor, Black, Bluetooth, broader, Card, career, cease, chance, circulatory, coagulation, college, Cultural, culture, DCEO, dedicated, digital, distancing, doubtful, East, EP, equitable, EUA, exempt, expedite, fighting, flattened, Flex, flu, FordPresident, Gallant, gas, gender, Gregory, guided, healthiest, heat, Hispanic, holistic, iCGM, IgG, IgM, Immunoglobulin, infected, internship, IonicRF, LA, Latino, Leadership, LGBTQ, lifted, Malta, mandatory, McDewDirector, member, mentoring, mission, motivating, multiplex, Network, older, onsite, outweighed, Panbio, pandemic, Parliament, PCR, physical, pipeline, play, polymerase, portable, postponed, PRIDE, priority, proper, put, quadrivalent, quarantine, race, reaction, RealTime, refractory, revert, revoked, role, rotate, rotational, routine, saving, school, Sense, serology, sexually, shifted, smartphone, social, sooner, Sport, stake, STEM, stop, syncytial, talent, talented, team, telehealth, temperature, Tetra, track, training, transmitted, TriClip, tricuspid, unpredictability, USA, usability, virtually, VOICE, workforce, workplace, young
Removed: add, ahead, AMO, Angel, announced, assay, assignment, attributable, backlog, Beckman, bore, brian, bridge, cashed, Chace, close, closely, combined, connectivity, Convertible, Coulter, Covidien, curtailment, divest, drawn, Epocal, equaled, exchanged, excise, exclude, expired, factoring, Femoseal, forma, France, generation, grew, hand, HBV, HCV, holding, Hong, ICM, imposed, Indonesia, Insertable, Johnson, Kong, leader, liable, likelihood, magnetic, meaningful, meant, medium, merger, MeterPro, Natriuretic, occurred, permitted, Perpetual, plant, Precision, preference, preferred, presence, pro, proactive, properly, provisional, qualify, Quidel, refinanced, relationship, repay, resonance, rounding, run, samuel, scott, secondarily, shaping, Sheath, Sierra, sourced, Steerable, stronger, subsequently, sum, suspended, tendered, Terumo, Triage, troubled, unaudited, unpaid, utilized, Vado, validly, Vault, withdrawn, yoor